The DOI matches its Crossref record; 471 of the 473 references it cites were found in a registry or an index.
Artificial intelligence and machine learning-aided drug discovery in central nervous system diseases: State-of-the-arts and future directions
Open accessAbstract
Neurological disorders significantly outnumber diseases in other therapeutic areas. However, developing drugs for central nervous system (CNS) disorders remains the most challenging area in drug discovery, accompanied with the long timelines and high attrition rates. With the rapid growth of biomedical data enabled by advanced experimental technologies, artificial intelligence (AI) and machine learning (ML) have emerged as an indispensable tool to draw meaningful insights and improve decision making in drug discovery. Thanks to the advancements in AI and ML algorithms, now the AI/ML-driven solutions have an unprecedented potential to accelerate the process of CNS drug discovery with better success rate. In this review, we comprehensively summarize AI/ML-powered pharmaceutical discovery efforts and their implementations in the CNS area. After introducing the AI/ML models as well as the conceptualization and data preparation, we outline the applications of AI/ML technologies to several key procedures in drug discovery, including target identification, compound screening, hit/lead generation and optimization, drug response and synergy prediction, de novo drug design, and drug repurposing. We review the current state-of-the-art of AI/ML-guided CNS drug discovery, focusing on blood-brain barrier permeability prediction and implementation into therapeutic discovery for neurological diseases. Finally, we discuss the major challenges and limitations of current approaches and possible future directions that may provide resolutions to these difficulties.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Sørlie, T., Perou, C. M., Tibshirani, R. J., Aas, T., Geisler, S. B., Johnsen, H., Hastie, T. J., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 11,506
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,526
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Random Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A. I., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,613
MoleculeNet: a benchmark for molecular machine learning
Wu, Z., Ramsundar, B., Feinberg, E. N., Gomes, J., Geniesse, C., Pappu, A. S., Leswing, K., & Pande, V. (2018) · Chemical Science · doi:10.1039/c7sc02664a · Cited by 3,107
Automatic Chemical Design Using a Data-Driven Continuous Representation of Molecules
Gómez-Bombarelli, R., Wei, J. N., Duvenaud, D., Hernández-Lobato, J. M., Sánchez-Lengeling, B., Sheberla, D., Aguilera-Iparraguirre, J., Hirzel, T. D., Adams, R. P., & Aspuru-Guzik, A. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00572 · Cited by 3,106
Mechanisms of Alternative Pre-Messenger RNA Splicing
Black, D. L. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161720 · Cited by 2,704
A Deep Learning Approach to Antibiotic Discovery
Stokes, J. M., Yang, K., Swanson, K., Jin, W., Cubillos-Ruiz, A., Donghia, N. M., MacNair, C. R., French, S., Carfrae, L. A., Bloom-Ackermann, Z., et al. (2020) · Cell · doi:10.1016/j.cell.2020.01.021 · Cited by 2,463
Schizophrenia: A Concise Overview of Incidence, Prevalence, and Mortality
McGrath, J., Saha, S., Chant, D., & Welham, J. (2008) · Epidemiologic Reviews · doi:10.1093/epirev/mxn001 · Cited by 2,280
Flagged first, then by citations
2 of the 473 references couldn’t be matched to a known paper.
Research works printed but not linked: 4
- Todeschini R, 2001, Books—handbook of molecular descriptors, Angew Chem, 40, 1977
- Matsumoto S, 2020, Extraction of protein dynamics information hidden in Cryo‐EM map using deep learning, bioRxiv
- DahlGE JaitlyN SalakhutdinovRMulti‐task neural networks for QSAR predictions.arXiv preprint arXiv:14061231.2014.
- 10.1038/s41563-019-0332-5 · DOI
Cited by
Sorted by citations
Items 101–200 of 429
Gou, R., Yang, J., Guo, M., Chen, Y., & Xue, W. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.4c00504 · Cited by 21
Current Approaches and Tools Used in Drug Development against Parkinson’s Disease
Koszła, O., Stępnicki, P., Zięba, A., Grudzińska, A., Matosiuk, D., & Kaczor, A. A. (2021) · Biomolecules · doi:10.3390/biom11060897 · Cited by 25
Neural Epidermal Growth Factor-Like Like Protein 2 Is Expressed in Human Oligodendroglial Cell Types
Shaker, M. R., Kahtan, A., Prasad, R., Lee, J., Pietrogrande, G., Leeson, H. C., Sun, W., Wolvetang, E. J., & Slonchak, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.803061 · Cited by 19
Zhou, Y., Zhao, W., Feng, Y. X., Niu, X., Dong, Y., & Chen, Y. (2022) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04703 · Cited by 20
Fatima, M., Hanif, S., Elsharkawy, E. R., Zafar, F., Zulfiqar, A., Khan, M. A., Akhtar, N., Fareed, Z., El-Bahy, Z. M., Shafiq, Z., et al. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.110921 · Cited by 20
In silico drug discovery: a machine learning-driven systematic review
Atasever, S. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03260-w · Cited by 29
Lee, C. (2024) · Sustainability · doi:10.3390/su16219516 · Cited by 20
Piezo-electronics: A paradigm for self-powered bioelectronics
Das, K. K., Pandey, R., & Dubey, A. K. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123118 · Cited by 18
In-silico Approaches for Drug Designing Technology: Bridging Discovery and Development
Islam, A., Jena, D., Mondal, N. S., Teli, A., Mondal, S., & Gautam, M. K. (2025) · Current Drug Discovery Technologies · doi:10.2174/0115701638326869250207060616 · Cited by 22
Wang, B., Liu, Q., Zhao, W., Zhang, T., Zhang, D., Sutcharitchan, C., & Li, S. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.030 · Cited by 25
Chen, S., Zhang, L., Chen, Y., & Fu, L. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01097 · Cited by 18
Application of Artificial Intelligence and Machine Learning in Drug Discovery and Development
Parvathaneni, M., Awol, A. K., Kumari, M., Lan, K., & Lingam, M. (2023) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v13i1.5867 · Cited by 20
Alshabrmi, F. M., Alkhayl, F. F. A., & Rehman, A. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.176661 · Cited by 19
Harnessing machine learning potential for personalised drug design and overcoming drug resistance
Hakami, M. A. (2024) · Journal of drug targeting · doi:10.1080/1061186x.2024.2365934 · Cited by 20
Singh, C. K., & Sodhi, K. K. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2429603 · Cited by 18
Nowak, I., Madej, M., Secemska, J., Sarna, R., & Strzałka‐Mrozik, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15071931 · Cited by 18
Ashiwaju, B. I., Orikpete, O. F., & Uzougbo, C. G. (2023) · Matrix Science Pharma · doi:10.4103/mtsp.mtsp_14_23 · Cited by 22
Designing drugs optimized for both blood–brain barrier permeation and intra-cerebral partition
Dichiara, M., Cosentino, G., Giordano, G., Pasquinucci, L., Marrazzo, A., Costanzo, G., & Amata, E. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2294118 · Cited by 17
Halicin: A New Horizon in Antibacterial Therapy against Veterinary Pathogens
Wang, S., Zhao, K., Chen, Z., Liu, D., Tang, S., Sun, C., Chen, H., Wang, Y., & Wu, C. (2024) · Antibiotics · doi:10.3390/antibiotics13060492 · Cited by 17
Aljarallah, N. A., Dutta, A. K., & Sait, A. R. W. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126422 · Cited by 17
Weng, J., Zhu, X., Ouyang, Y., Liu, Y., Lu, H., Yao, J., & Pan, B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04461-5 · Cited by 17
Kumar, S. (2025) · International Journal of Scientific Research and Management (IJSRM) · doi:10.18535/ijsrm/v13i04.mp02 · Cited by 17
Uzundurukan, A., Nelson, M., Teske, C., Islam, M. S., Elzagheid, M. I., Christy, J. V., Martin, H., Muratov, E. N., Glover, S., & Fuoco, D. (2025) · The Pharmacogenomics Journal · doi:10.1038/s41397-025-00368-z · Cited by 16
ProfhEX: AI-based platform for small molecules liability profiling
Lunghini, F., Fava, A., Pisapia, V., Sacco, F. M., Iaconis, D., & Beccari, A. R. (2023) · Journal of Cheminformatics · doi:10.1186/s13321-023-00728-6 · Cited by 17
Haneczok, J., Delijewski, M., & Moldzio, R. (2023) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2023.107731 · Cited by 18
Emerging biophysical techniques for probing synaptic transmission in neurodegenerative disorders
Kale, M. B., Wankhede, N. L., Bishoyi, A. K., Ballal, S., Kalia, R., Arya, R., Kumar, S., Khalid, M., Gulati, M., Umare, M. D., et al. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.11.055 · Cited by 17
Nishan, M. N. H. (2025) · Journal of Global Health · doi:10.7189/jogh.15.03002 · Cited by 21
A Comprehensive Review of the Impact of Machine Learning and Omics on Rare Neurological Diseases
Alganmi, N. A. (2024) · BioMedInformatics · doi:10.3390/biomedinformatics4020073 · Cited by 19
Regenerative bioelectronics: A strategic roadmap for precision medicine
Panda, A. K., & Basu, B. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122271 · Cited by 14
Anti-NMDAR antibodies, the blood–brain barrier, and anti-NMDAR encephalitis
Gong, X., Wang, N., Zhu, H., Tang, N., Wu, K., & Meng, Q. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1283511 · Cited by 18
Revolutionizing Drug Discovery: The Role of Artificial Intelligence and Machine Learning
Verma, A., & Awasthi, A. (2024) · Current Pharmaceutical Design · doi:10.2174/0113816128298691240222054120 · Cited by 17
Yadav, M. K., Dahiya, V., Tripathi, M. K., Chaturvedi, N., Rashmi, M., Ghosh, A., & Raj, V. S. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177103 · Cited by 19
An in-depth review of AI-powered advancements in cancer drug discovery
Le, M. H. N., Nguyen, P. K., Nguyen, T. P. T., Nguyen, H. Q., Tam, D. N. H., Huynh, H. H., Huynh, P. K., & Le, N. Q. K. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167680 · Cited by 15
Strategies to identify candidate repurposable drugs: COVID-19 treatment as a case example
Imami, A. S., McCullumsmith, R. E., & O'Donovan, S. M. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01724-w · Cited by 17
Zarei, O., moghaddam, M. T., & Vastegani, S. M. (2025) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2025.111667 · Cited by 21
Zhang, Z., Huang, D., Feng, J., Li, W., Wang, Z., Lu, M., Luo, Y., Yang, W., Xu, Z., Xie, Q., et al. (2024) · Interdisciplinary medicine · doi:10.1002/inmd.20230062 · Cited by 16
Zhang, H., Zhou, Y., Zhang, Z., Sun, H., Pan, Z., Mou, M., Zhang, W., Ye, Q., Hou, T., Li, H., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c01793 · Cited by 15
Subhashini, S. M., Sriram, S., & Nivethitha, V. (2024) · International Conference on Communication, Computer Sciences and Engineering (IC3SE) · doi:10.1109/ic3se62002.2024.10593380 · Cited by 14
Aritra, S., Shikha, C. B., & Indu, S. (2025) · Intelligent Pharmacy · doi:10.1016/j.ipha.2024.12.001 · Cited by 18
Single-step retrosynthesis prediction via multitask graph representation learning
Zhao, P., Wei, X.-X., Wang, Q., Wang, Q.-H., Li, J.-N., Shang, J., Lu, C. C., & Shi, J. (2025) · Nature Communications · doi:10.1038/s41467-025-56062-y · Cited by 22
Brain Network Dynamics and Multiscale Modeling of Neurodegenerative Disorders: A Review
Shaheen, H., & Melnik, R. (2025) · IEEE Access · doi:10.1109/access.2025.3542634 · Cited by 19
Singh, S. K., Kumar, A., Singh, R. B., Ghosh, P., & Bajad, N. G. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666221026091010 · Cited by 16
Iraji, M. S., Tanha, J., & Habibinejad, M. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.106276 · Cited by 13
Artificial Intelligence in the Paradigm Shift of Pharmaceutical Sciences: A Review
Tade, R. S., Jain, S. N., Satyavijay, J. T., Shah, P. N., Bari, T. D., Patil, T. M., & Shah, R. P. (2023) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2023.9290043 · Cited by 19
Machine Learning and Artificial Intelligence in Therapeutics and Drug Development Life Cycle
Borkotoky, S., Joshi, A., Kaushik, V., & Jha, A. N. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104753 · Cited by 16
Wong, D. R., Conrad, J. C., Johnson, N. R., Ayers, J. I., Laeremans, A., Lee, J. C., Lee, J., Prusiner, S. B., Bandyopadhyay, S., Butte, A. J., et al. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-022-00490-8 · Cited by 13
Applications of artificial intelligence in drug discovery for neurological diseases
Ekins, S., & Lane, T. R. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00624 · Cited by 12
Kubatka, P., Huniadi, M., Kapinová, A., Nosálová, N., Varghese, E., Blahútová, D., Horňák, S., Trbolova, A., Biringer, K., Adamicová, K., et al. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.10.067 · Cited by 12
Nguyen, M. H., Tran, N. D., & Le, N. Q. K. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867331666230913105829 · Cited by 10
Improving glioma drug delivery: A multifaceted approach for glioma drug development
Yonk, M. G., Lim, M. A., Thompson, C. M., Tora, M. S., Lakhina, Y., Du, Y., Hoang, K. B., Molinaro, A. M., Boulis, N. M., Hassaneen, W., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107390 · Cited by 12
Sun, D., Macedonia, C. R., Chen, Z., Chandrasekaran, S., Najarian, K., Zhou, S. Y., Cernak, T., Ellingrod, V. L., Jagadish, H. V., Marini, B. L., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01684 · Cited by 14
Drug repositioning for Parkinson’s disease: An emphasis on artificial intelligence approaches
Karimi-Sani, I., Sharifi, M., Abolpour, N., Lotfi, M., Atapour, A., Takhshid, M. A., & Sahebkar, A. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102651 · Cited by 13
RNA research for drug discovery: Recent advances and critical insight
Aja, P. M., Agu, P. C., Ogbu, C. O., Alum, E. U., Fasogbon, I. V., Musyoka, A. M., Ngwueche, W., Egwu, C. O., Tusubira, D., & Ross, K. (2025) · Gene · doi:10.1016/j.gene.2025.149342 · Cited by 17
Emerging perspectives of synaptic biomarkers in ALS and FTD
Krishnamurthy, K., & Pradhan, R. K. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1279999 · Cited by 13
Artificial intelligence in anesthesia and perioperative medicine
Fei, Q., Zhang, Y., Liu, C., Zheng, J., & Fu, Q. (2025) · Anesthesiology and Perioperative Science · doi:10.1007/s44254-025-00107-4 · Cited by 15
Gu, Z., Ge, B., Wang, Y., Gong, Y., & Qi, M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1609063 · Cited by 12
Aljazzar, S. O. (2024) · Journal of the Indian Chemical Society · doi:10.1016/j.jics.2024.101125 · Cited by 11
Innovation in nanomedicine: nanocarriers for central nervous system disorders management
Waqar, M. A., Mubarak, N., Khan, A. M., Ahmad, S., Zaib, M., Kanwal, U., Khan, I. N., Ayesha, M., Mughal, M., & Fahad, M. (2024) · International Journal of Polymeric Materials · doi:10.1080/00914037.2024.2399271 · Cited by 11
Niazi, S. K. (2025) · Pharmaceuticals · doi:10.3390/ph18070951 · Cited by 11
Wu, X.-L., Li, Z., Chen, G., Yin, Y., & Chen, C. Y. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1227371 · Cited by 12
Wang, Z., & Guo, Z. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3639-7 · Cited by 10
Ghosh, A., Choudhary, G. P., & Medhi, B. (2024) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_81_24 · Cited by 9
Recent developments and applications of artificial intelligence in solid/liquid extraction studies
Salamat, Q., Gümüş, Z. P., & Soylak, M. (2024) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2024.118057 · Cited by 10
Chhina, A., Trehan, K., Saini, M., Thakur, S., Kaur, M., Shahtaghi, N. R., Shivgotra, R., Soni, B., Modi, A., Bakrey, H., et al. (2023) · Current Pharmaceutical Design · doi:10.2174/1381612829666230807161421 · Cited by 12
Wang, X., Li, Z., & Wu, H. (2023) · IEEE Access · doi:10.1109/access.2023.3314699 · Cited by 10
Bhoi, A., Dwivedi, S. D., Singh, D., Keshavkant, S., & Singh, M. R. (2023) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.2023048324 · Cited by 11
cyclicpeptide: a Python package for cyclic peptide drug design
Liu, Y., Cao, S., Liu, L., Zhu, R., & Wu, D. (2024) · Briefings in Bioinformatics · doi:10.1093/bib/bbae714 · Cited by 10
A Review on the Recent Advancements and Artificial Intelligence in Tablet Technology
Sahu, A., Rathee, S., Saraf, S., & Jain, S. (2024) · Current Drug Targets · doi:10.2174/0113894501281290231221053939 · Cited by 9
Wu, C.-C., Poly, T. N., Weng, Y.-C., Lin, M., & Islam, M. M. (2024) · Diagnostics · doi:10.3390/diagnostics14151594 · Cited by 9
Mubarak, N., Waqar, M. A., Khan, A. M., Asif, Z., Alvi, A. S., Virk, A. A., & Amir, S. (2025) · Designed Monomers & Polymers · doi:10.1080/15685551.2025.2464132 · Cited by 10
Vidiyala, N., Sunkishala, P., Parupathi, P. R., & Nyavanandi, D. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03134-3 · Cited by 10
Hong, F., Chen, Q., Luo, X., Xie, S., Wei, Y., Li, X., Li, K., Lebeau, B., Ling, C. C. Y., Dao, F., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157640 · Cited by 9
Healthcare and cutting-edge technology: Advancements, challenges, and future prospects
Singhal, V., Shyam, R., Singhal, S., Tiwari, A., & Mangal, D. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.110861 · Cited by 13
Intelligence on the graph: Graph neural networks for mechanistic drug target discovery
Chen, J., Fan, N., Lu, Y., Yang, J., Song, W., Sheng, H., Yang, Y., Chen, S., & Wang, J. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101508 · Cited by 11
A review of deep learning approaches for drug synergy prediction in cancer
Li, L., Zhang, H., Zheng, C., & Su, Y. (2025) · npj Drug Discovery. · doi:10.1038/s44386-025-00034-1 · Cited by 11
Praveen, S. V., & Lohia, R. (2023) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2023.103626 · Cited by 9
Artificial Intelligence-Supported Systems in Anesthesiology and Its Standpoint to Date—A Review
Pham, F. M. P. (2023) · Open Journal of Anesthesiology · doi:10.4236/ojanes.2023.137014 · Cited by 9
Anti-Viral Activity of Bioactive Molecules of Silymarin against COVID-19 via In Silico Studies
Zhang, C., Sui, Y., Liu, S., & Yang, M. J. (2023) · Pharmaceuticals · doi:10.3390/ph16101479 · Cited by 9
Kim, Y., & Kim, S. (2023) · Psychiatry Investigation · doi:10.30773/pi.2022.0343 · Cited by 9
Khastehband, S., Dabbaghi, K. G., Khosravirad, Z., Jamalnia, S., GhorbaniNia, R., Mahmoudikohani, F., & Zakeri, H. (2023) · Galen Medical Journal · doi:10.31661/gmj.v12i.3061 · Cited by 9
Directions for analgesic development
Ge, T., Wu, Z., Sha, S., Yang, X., Liu, H., Song, L., & Zhang, H. (2024) · Journal of Anesthesia and Translational Medicine · doi:10.1016/j.jatmed.2024.08.003 · Cited by 8
Yang, J., Huang, E. P., Liao, K. Y.-K., BAU, D.-T., Tsai, S.-C., Chen, C., Chen, K., Liu, T.-Y., Chiu, Y.-J., & Tsai, F. (2024) · Biomedicine · doi:10.37796/2211-8039.1474 · Cited by 8
Artificial Intelligence and Machine Learning in Tropical Disease Management
Ogwu, M. C., & Izah, S. C. (2025) · Health information science · doi:10.1007/978-3-031-82622-1_7 · Cited by 8
Artificial intelligence optimizes the standardized diagnosis and treatment of chronic sinusitis
Liu, Y.-Y., Jiang, S.-P., & Wang, Y. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1522090 · Cited by 10
Evaluating the Impact of AI-Based Model-Informed Drug Development (MIDD): A Comparative Review
Mao, B., Gao, Y., Xu, C. R., Macha, S., Shuai, S. H. A. O., & Ahamadi, M. (2025) · The AAPS Journal · doi:10.1208/s12248-025-01075-0 · Cited by 9
Ahad, A., Ahmed, K. I., Ullah, F., Sheikh, M. A., Tahir, M., Hayajneh, M., & Pires, I. M. (2026) · Wiley Interdisciplinary Reviews Data Mining and Knowledge Discovery · doi:10.1002/widm.70065 · Cited by 9
Chen, Y., Ding, Y., Lin, H., & Shi, J. (2026) · Chemical Society Reviews · doi:10.1039/d5cs01323b · Cited by 9
Alsanousi, W. A., Ahmed, N. Y., Hamid, E. M., Elbashir, M. K., Musa, M. E. M., Wang, J., Khan, N., & Afnan, A. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275195 · Cited by 8
Harnessing deep learning into hidden mutations of neurological disorders for therapeutic challenges
Yang, S., Kim, S.-H., Kang, M., & Joo, J. (2023) · Archives of Pharmacal Research · doi:10.1007/s12272-023-01450-5 · Cited by 8
Cui, J., Miao, X., Yanghao, X., & Qin, X. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1171167 · Cited by 8
Larson, K. C., Martens, L. H., Marconi, M., Dejesus, C., Bruhn, S., Miller, T. A., Tate, B. A., & Levenson, J. M. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03029-3 · Cited by 9
Precision Psychiatry: Machine Learning as a Tool to Find New Pharmacological Targets
Rema, J., Novais, F., & Telles‐Correia, D. (2021) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026621666211004095917 · Cited by 8
Precision medicine in public health in India: Nascent but poised in the right direction
Yadav, A. K., & Sagar, R. (2021) · Indian Journal of Public Health · doi:10.4103/ijph.ijph_1728_21 · Cited by 8
In-depth Analysis of Artificial Intelligence for Climate Change MitigationPreprint
Lu, L. (2024) · Preprints.org · doi:10.20944/preprints202402.0022.v1 · Cited by 7
A Review of Drug-related Associations Prediction Based on Artificial Intelligence Methods
Ma, M., Lei, X., & Zhang, Y. (2023) · Current Bioinformatics · doi:10.2174/1574893618666230707123817 · Cited by 7
Bhat, K. A., & Sofi, S. A. (2024) · International Journal of Information Technology · doi:10.1007/s41870-024-02120-5 · Cited by 7
Systems Thinking on Artificial Intelligence Integration into Higher Education: Causal Loops
Liew, Y. Z., Tan, A. H. P., Yap, E. H., Lim, C. S., Majeed, A. P. P. A., Zhu, Y., Chen, W., Chen, S.-H., & Lo, J. Y. T. (2024) · IntechOpen eBooks · doi:10.5772/intechopen.1008246 · Cited by 12
Olia, J. B. H., Raman, A., Hsu, C., Alkhayyat, A., & Nourazarian, A. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109984 · Cited by 9
Uddin, M. J., Gholap, A. D., Khan, T., Proma, A. Y., Masud, S., Choonara, Y. E., Gowri, S. S., Webster, T. J., & Faiyazuddin, M. (2024) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2024.3933 · Cited by 8
Shen, X., Zhang, H., Zhang, P., Niu, X., Zhao, X., Zhu, L., Zhu, J., & Wang, S. (2025) · Food Chemistry X · doi:10.1016/j.fochx.2025.102544 · Cited by 7
Metadata
- Authors
- Vatansever, S., Schlessinger, A., Wacker, D., Kaniskan, H. Ü., Jin, J., Zhou, M., & Zhang, B.
- Affiliations
- Icahn School of Medicine at Mount Sinai (US)
- Department of Pharmacological Sciences Icahn School of Medicine at Mount Sinai New York New York USA
- Tisch Cancer Institute (US)
- Corresponding author
- Zhang, Bin
- Venue
- Medicinal Research Reviews
- Publisher
- Wiley
- Published
- 2020-12-09
- Volume
- 41
- Issue
- 3
- Pages
- 1427-1473
- ISSN
- 0198-6325 (ISSN-L)
- 1098-1128
- PMC
- PMC8043990
- OpenAlex
- W3112951420
- Cited by
- 429
- References
- 473
- Citations by year
- 2026: 64 · 2025: 126 · 2024: 127 · 2023: 62 · 2022: 34 · 2021: 16
- FWCI
- 2.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Medicinal Research Reviews (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (U01AG058635, R01AG057907, U01AG046170, RF1AG054014, R01AG068030, RF1AG057440, RF1AG059319, R01AG062355, U01AG052411, R01AG072562)
- National Institute of General Medical Sciences (R35GM133504)
- National Institute of Allergy and Infectious Diseases (R01AI124465)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Keywords
- artificial intelligence in drug discovery, machine learning, central nervous system disorders, neurological disorders, target identification, compound screening, drug synergy prediction, de novo drug design, drug repurposing, drug attrition
- MeSH terms
- Machine Learning, Algorithms, Artificial Intelligence, Central Nervous System Diseases, Humans, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review